Form 4 for LQDA Liquidia Corp
Accepted 2024-01-16 00:00:00 ET · period of report 2024-01-11 · accession 0001104659-24-004155 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-16 | 2024-01-11 | LQDA | Saggar Rajeev | Chief Medical Off | A - Grant | $0.00 | +56.5K | 220.6K | +34% | $0 |
| D | 2024-01-16 | 2024-01-11 | LQDA | Saggar Rajeev | Chief Medical Off | A - Grant | $0.00 | +56.5K | 56.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-11 | A | A | 56,492 | $0.00 | 220,591 | D | — | — | (F2) 25% of the RSUs shall vest on January 11, 2025 and the remaining RSUs shall vest ratably on a quarterly basis over three years thereafter. (F3) Includes (i) 46,052 unvested RSUs of the 93,834 RSUs granted to the Reporting Person on July 18, 2022, (ii) 83,333 RSUs granted to the Reporting Person on January 11, 2023 and (iii) 1,189 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. |
| 2 | Derivative | Performance Stock Units | 2024-01-11 | A | A | 56,492 | $0.00 | 56,492 | D | — · — to — | 56,492 Common Stock | (F4) Each performance stock unit ("PSU") converts into one share of the Issuer's common stock. (F5) On January 11, 2024, the Reporting Person was granted 56,492 PSUs. The PSUs shall vest upon the later of (A) the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter and (B) the first commercial sale of YUTREPIA by the Issuer. |